Varian Medical Systems, Inc. Co (NYSE:VAR):
Varian and McKesson Specialty Health Announce Strategic Agreement for Advanced Radiotherapy Equipment and Software.
The company is up by 0.14% since yesterday’s close of $89.96.
It is trading at $90.09 which is slightly below $96.83, the 50 day moving average and slightly over the 200 day moving average of $89.44. The 50 day moving average went down by -6.96% and the 200 day average moved up $0.65.
Varian Medical Systems, Inc. Co’s P/E ratio is 21.50 and market capitalization is 8.44B. As of the last earnings report the EPS was $4.19 and is expected to be $4.97 for the current year with 93,699,000 shares now outstanding. Next quarter’s EPS is forecasted at $1.18 and the next full year EPS is anticipated to be $5.46.
Several Wall Street investment firms have weighed in on the company of late. On July 28 Jefferies made no change to the stock rating of “Neutral” and moved up the price target from $85.00 to $88.00. July 28 investment analysts at Citigroup kept the stock rating at “Buy” but raised the price target to $87.00 from $81.00.
January 28 investment analysts at Jefferies left the stock rating at “Buy” but lowered the price expectation to $85.00 from $90.00. Equity analyst Barrington Research issued its first research report on the stock with a rating of “Outperform” and establishing a price target of $91.00.
On December 22 analysts at RBC Capital starting coverage on the stock setting a rating of “Sector Perform” and price target of $86.00. On November 12, 2015 Citigroup initiated coverage on the stock giving it an initial rating of “Neutral” and projecting a price target of $81.00.